A Systematic and Evidence-Based Review of Published and Pending Reports of Andexanet Alfa
{{output}}
Andexanet alfa is the newly approved factor Xa inhibitor reversal agent for the treatment of life-threatening or uncontrolled bleeding from apixaban or rivaroxaban. This decoy protein directly binds factor Xa inhibitors reversing their action. A systematic and... ...
